explore -WSS

explore

author：entertainment 2025-09-29 01:09:15 - browse：782

3d rendered medically accurate illustration of the adrenal gland – biotech and pharma coverage from STAT — Adobe

SAN DIEGO — Neurocrine Biosciences announced on Tuesday that an experimental drug for congenital adrenal hyperplasia succeeded in a late-stage trial, bringing the company a step closer to treating patients with a rare and serious set of genetic disorders that alters their ability to produce key hormones.

In the Phase 3 study, known as CAHtalyst, 182 adults were randomly assigned to receive a placebo or crinecerfont, an oral drug Neurocrine developed to lower male sex hormones patients with the disease produce in excess. Researchers found that, compared to those on placebo, participants who took crinecerfont needed a significantly lower dose of the current standard-of-care treatment, glucocorticoids, after 24 weeks of treatment that they did at the study’s start. And about 63% of participants who took crinecerfont were able to lower their dose of glucocorticoids to levels researchers think would be safer for prolonged use, compared to 18% of those on the placebo.

Neurocine, a San Diego biotech focused on treating rare neurological and endocrine diseases, believes the drug could allow people living with congenital adrenal hyperplasia, or CAH, to avoid some of the more serious side effects of glucocorticoids by allowing them to take lower doses. Long-term use of high doses of these drugs can cause patients to gain weight and put them at risk of diabetes, heart disease, and osteoporosis.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Living with Hashimoto's and celiac disease, and med school, too

hotspot

WSS

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Jury awards Florida girl burned by McDonald's Chicken McNugget $800,000 in damages

Congress must give Medicare recipients genetic counseling access

As Maui death toll rises, number of missing remains unclear

Hilary expected to bring catastrophic, life

Evacuations in place as 3 wildfires burn in eastern Washington state

focus

explore

Wikipedia

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

FDA approves first treatment for ultra

United colonoscopy coverage change 'may cost lives,' doctors say

Liz Cheney makes 1st public comment since Trump's election interference indictments

Sports medicine is finally prioritizing gender equality

The pain doctors face in trying to build their families

Medical leaders decry Supreme Court decision on affirmative action

'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

Anesthesiologist group: stop taking Ozempic before surgery

A Q&A with Gavi’s Seth Berkley on vaccines, Covid, and more

hotspot

Wife of Gilgo Beach murder suspect files for divorce, court filing shows

Trump cancels press conference intended to dispute Georgia election interference charges

Congress must give Medicare recipients genetic counseling access

Vir antibody drug aimed at influenza A fails in clinical trial

Hilary expected to bring catastrophic, life

Baltimore teen accused of firing into crowd during block party mass shooting

knowledge

hotspot

hotspot

entertainment